American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

Luminex Corp.'s c. difficile assay attains FDA clearance

American Pharmacy News Reports | Jul 31, 2017
C. difficile is an urgent threat as it is now the most common microbial cause of health care-associated infections in U.S. hospitals.

Luminex Corporation recently announced that its ARIES clostridium difficile (c. difficile) assay has been given U.S. Food and Drug Administration (FDA) clearance. Read More »

Therigy partners with EPI-W to expand research on specialty pharmacy outcomes

American Pharmacy News Reports | Jul 28, 2017
Therigy noted that EPI-Q brings more than 20 years of experience to the research table.

Therigy, a company that pioneered patient-focused specialty therapy management, recently announced a strategic partnership with EPI-Q Inc. to expand research on specialty pharmacy outcomes. Read More »

AstraZeneca taps Biologics to distribute carcinoma drug

American Pharmacy News Reports | Jul 28, 2017
Patients diagnosed with advance bladder cancer often start receiving platinum-containing chemotherapy.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by AstraZeneca to distribute Imfinzi. Read More »

Optum and Merck simulate contractual reimbursement models

American Pharmacy News Reports | Jul 26, 2017
The companies will use a shared laboratory to explore both value-based and pay-for-performance models.

Optum, UnitedHealth Group’s health services business, and Merck recently announced collaboration on developing and simulating the performance of contractual reimbursement models that align payment for prescription drugs with patient health outcomes. Read More »

Amgen, Array BioPharma pool efforts to attack autoimmune disorders

American Pharmacy News Reports | Jul 25, 2017
Array BioPharma leaders referred to Amgen as “a leader in treatments for inflammatory disease.”

Amgen of Thousand Oaks, California and Array BioPharma of Boulder, Colorado recently created a cooperative contract to develop innovative drugs aimed at combating autoimmune disorders after Array’s breakthrough discovery of certain target and lead inhibitors. Read More »

Australian institutes pool resources to treat diabetes, obesity

American Pharmacy News Reports | Jul 25, 2017
UniQuest specializes in commercializing intellectual property and research results.

Launching a four-year research program to develop diabetes and obesity treatments, PreveCeutical Medical Inc. of Vancouver, British Columbia recently signed an agreement with UniQuest Pty Ltd. of the University of Queensland in Australia. Read More »

GE Healthcare attains Novia Strategies to build capacity for improved outcomes

American Pharmacy News Reports | Jul 22, 2017
GE Healthcare Camden Group has served over 2,400 health care facilities and systems.

Joining forces with experienced clinicians from Novia Strategies, GE Healthcare recently acquired the 22-year-old California-founded consulting group to enhance its capability for driving optimal outcomes through organizational improvement. Read More »

AmeriHealth Caritas Louisiana earns NCQA distinction

American Pharmacy News Reports | Jul 22, 2017
AmeriHealth Caritas Louisiana strives to serve all populations.

Demonstrating excellence in overcoming cultural barriers to quality care, Medicaid managed health care plan AmeriHealth Caritas Louisiana of Baton Rouge recently merited an honor from the National Committee for Quality Assurance (NCQA). Read More »

Magellan strikes deal to acquire Senior Whole Health

American Pharmacy News Reports | Jul 22, 2017
Magellan operates specialized managed care plans.

Magellan Health Inc. struck a deal this month to acquire Senior Whole Health, a provider of Medicare and Medicaid to dual-eligible clients in Massachusetts and New York. Read More »

Merck to partner with F-Star on bispecific immuno-oncology antibodies

American Pharmacy News Reports | Jul 21, 2017
Merck will be able to replace and add to these antibodies by using F-Star’s bispecific antibody platform.

Merck KGaA will collaborate with F-Star, a biopharmaceutical company in the United Kingdom, to develop and commercialize five bispecific immuno-oncology antibodies. Read More »

West Pharmaceutical Services presents at InnoPack Pharma Confex

American Pharmacy News Reports | Jul 21, 2017
The presentation capped a weeklong series of seminars and educational activities.

West Pharmaceutical Services Inc. presented on best practices for improving patient outcomes through integrated containment and delivery systems at the Sixth Annual InnoPack Pharma Confex in Mumbai, India. Read More »

Rennova Health to spin off AMSG division to public ownership

American Pharmacy News Reports | Jul 19, 2017
Rennova’s board of directors previously authorized a spinoff of its Health Technology Solutions business.

Via tax-free allotment to company shareholders, Rennova Health Inc. intends to transition its Advanced Molecular Services Group to a publicly traded entity by late September pending appropriate paperwork with the SEC and other conditions. Read More »

Maxor to manage pair of D.C. pharmacies for Unity Health Care

American Pharmacy News Reports | Jul 11, 2017
Maxor provides a range of services including pharmacy management, consulting and pharmacy benefit management.

Texas-based Maxor National Pharmacy Services LLC recently unveiled two on-site pharmacy shops for Unity Health Care's Parkside and Upper Cardozo Health Centers, both with physical locations serving the community in Washington, D.C. Read More »

Endo cuts ties with Litha Healthcare Group

American Pharmacy News Reports | Jul 10, 2017
Endo has received $100 million at closing and may be able to receive $11 million more in assets from Litha.

Endo International PLC has finalized the divestiture of Litha Healthcare Group to Acino Pharma AG. Read More »

Baxter and Tel Aviv University create new licensing agreement

American Pharmacy News Reports | Jul 8, 2017
The agreement will facilitate the relationship between Baxter, TAU and TASMC.

Baxter International Inc. and Tel Aviv University through Ramot have entered a new licensing agreement that will be assessing technologies that are being developed at the university and Tel Aviv Sourasky Medical Center. Read More »

Novo Nordisk recalls cartridge holders

American Pharmacy News Reports | Jul 7, 2017
The batches in question were dispensed between Aug. 1, 2016 and June 22, 2017.

Novo Nordisk is recalling insulin cartridge holders of the NovoPen Echo model, warning that they may crack if they are in the presence of chemicals, such as those found in cleaners. Read More »

McKesson acquires intraFUSION

American Pharmacy News Reports | Jul 7, 2017
The acquisition closely relates to McKesson's overall goal of increasing the quality of specialty care.

McKesson Specialty Health has acquired intraFUSION. Read More »

DelMar leaders join brain tumor society's research roundtable

American Pharmacy News Reports | Jul 6, 2017
Jeffrey Bacha and Dennis Brown participated alongside peers in the neuro-oncology field.

Two DelMar Pharmaceuticals Inc. executives recently accepted requests to join the National Brain Tumor Society's Research Roundtable, attending its premiere meeting in Washington, D.C. to consider ways research can improve clinical trials for regulatory approval. Read More »

Pfizer study shows Xeljanz on par with Humira for treating rheumatoid arthritis

American Pharmacy News Reports | Jul 6, 2017
Xeljanz is a twice-daily monotherapy to be used in combination with methotrexate.

Pfizer Inc. recently published noninferiority results from its study of Xeljanz, a twice-daily monotherapy to be used in combination with methotrexate in treating patients with moderate to severe rheumatoid arthritis. Read More »

Takeda, Biological E offer low-cost vaccine combos for Asia

American Pharmacy News Reports | Jun 30, 2017
Takeda will transfer to BE its existing technology for bulk vaccine production.

The rights to vaccine technologies designed to combat measles and pertussis will be transferred to an India-based business following a pair of recent licensing agreements to hasten affordable protection in India, China and additional nations. Read More »

  • «
  • 1
  • 2
  • ...
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • ...
  • 31
  • 32
  • »
Trending

Shaun Noorian, CEO of Empower Pharmacy

Empower Pharmacy challenges Eli Lilly tirzepatide patent before U.S. Patent Trial and Appeal Board

David Balto, Former Policy Director at the Federal Trade Commission

Former FTC director on 340B program: ‘Drug discounts are being captured by corporate hospital systems'

Mary Holland, CEO of CHD

Poll finds majority want pharma accountable for vaccine injuries

Melissa Magstadt, Secretary of Health

South Dakota issues air quality alert due to wildfire smoke

Danea Horn, Researcher, University of California

Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up